berberine has been researched along with Cytokine Release Syndrome in 1 studies
Cytokine Release Syndrome: A severe immune reaction characterized by excessive release of CYTOKINES. Symptoms include DYSPNEA; FEVER; HEADACHE; HYPOTENSION; NAUSEA; RASH; TACHYCARDIA; HYPOXIA; HYPERFERRITINEMIA, and MULTIPLE ORGAN FAILURE. It is associated with viral infections, SEPSIS; AUTOIMMUNE DISEASES and a variety of factors used in IMMUNOTHERAPY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, BY | 1 |
| Chen, M | 1 |
| Chen, XC | 1 |
| Cao, K | 1 |
| You, Y | 1 |
| Qian, YJ | 1 |
| Yu, WK | 1 |
1 other study available for berberine and Cytokine Release Syndrome
| Article | Year |
|---|---|
Berberine reduces circulating inflammatory mediators in patients with severe COVID-19.
Topics: Anti-Inflammatory Agents; Antiviral Agents; Berberine; COVID-19; COVID-19 Drug Treatment; Cytokine R | 2021 |